These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 39028785)

  • 81. Update on the evaluation, pathogenesis, and management of neurogenic orthostatic hypotension: introduction.
    Low PA
    Neurology; 1995 Apr; 45(4 Suppl 5):S4-5. PubMed ID: 11536688
    [No Abstract]   [Full Text] [Related]  

  • 82. Midodrine for orthostatic hypotension and recurrent reflex syncope: A systematic review.
    Izcovich A; González Malla C; Manzotti M; Catalano HN; Guyatt G
    Neurology; 2014 Sep; 83(13):1170-7. PubMed ID: 25150287
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Syncope in pharmacologically unmasked Brugada syndrome: indication for an implantable defibrillator or an unresolved dilemma?
    Samniah N; Iskos D; Sakaguchi S; Lurie KG; Benditt DG
    Europace; 2001 Apr; 3(2):159-63. PubMed ID: 11333057
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Potential risk of vasovagal syncope for motor vehicle driving.
    Li H; Weitzel M; Easley A; Barrington W; Windle J
    Am J Cardiol; 2000 Jan; 85(2):184-6. PubMed ID: 10955374
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Meta-analysis of beta-adrenoceptor blockers for the treatment of vasovagal syncope].
    Liao Y; Li XY; Zhang YW; Du JB
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Dec; 40(6):603-9. PubMed ID: 19088832
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Heart rate and blood pressure variability in subjects with vasovagal syncope.
    Piccirillo G; Naso C; Moisè A; Lionetti M; Nocco M; Di Carlo S; De Laurentis T; Magrì D; Cacciafesta M; Marigliano V
    Clin Sci (Lond); 2004 Jul; 107(1):55-61. PubMed ID: 14982493
    [TBL] [Abstract][Full Text] [Related]  

  • 87. NET-NET: are norepinephrine transport inhibitors a potentially useful therapy for vasovagal syncope?
    Roukoz H; Benditt DG
    J Cardiovasc Electrophysiol; 2013 Jul; 24(7):804-5. PubMed ID: 23574151
    [No Abstract]   [Full Text] [Related]  

  • 88. The role of tilt training in preventing recurrent syncope in patients with vasovagal syncope: a prospective and randomized study.
    Duygu H; Zoghi M; Turk U; Akyuz S; Ozerkan F; Akilli A; Erturk U; Onder R; Akin M
    Pacing Clin Electrophysiol; 2008 May; 31(5):592-6. PubMed ID: 18439174
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Head-up tilt test for recurrent syncope in pilots.
    Carter D; Pokroy R; Grossman A; Azaria B; Goldstein L
    Aviat Space Environ Med; 2005 Dec; 76(12):1167-9. PubMed ID: 16370268
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Serotonin reuptake inhibition for the prevention of vasovagal syncope: a systematic review and meta-analysis.
    Raj P; Lei L; Flevaris P; Raj S; Sheldon R
    Clin Auton Res; 2023 Dec; 33(6):811-819. PubMed ID: 37971641
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Overview on the management of vasovagal syncope].
    Filali T; Fehri W; Lahidheb D; Hajlaoui N; Salah O; Barakett N; Smiri Z; Mhenni H; Haouala H
    Tunis Med; 2007 Oct; 85(10):814-20. PubMed ID: 18236801
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Clinical experience with Thera DR rate-drop response pacing algorithm in carotid sinus syndrome and vasovagal syncope. The International Rate-Drop Investigators Group.
    Benditt DG; Sutton R; Gammage MD; Markowitz T; Gorski J; Nygaard GA; Fetter J
    Pacing Clin Electrophysiol; 1997 Mar; 20(3 Pt 2):832-9. PubMed ID: 9080522
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Evaluation of the effects of diverse therapeutic treatments versus no treatment of patients with neurocardiogenic syncope].
    Di Girolamo E; Di Iorio C; Sabatini P; Leonzio L; Barsotti A
    Cardiologia; 1998 Aug; 43(8):833-7. PubMed ID: 9808874
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Evaluation and management of syncope.
    Veltmann C; Borggrefe M; Wolpert C; Schimpf R
    Minerva Cardioangiol; 2010 Dec; 58(6):701-15. PubMed ID: 21135810
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Ivabradine in treatment of sinus tachycardia mediated vasovagal syncope.
    Sutton R; Salukhe TV; Franzen-McManus AC; Collins A; Lim PB; Francis DP
    Europace; 2014 Feb; 16(2):284-8. PubMed ID: 24072450
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The usefulness of tilt testing with an intravenous beta-blocker in assessing the efficacy of long-term therapy in patients with vasovagal syncope.
    Gielerak G; Makowski K; Dłuzniewska E; Stec A; Cholewa M
    Kardiol Pol; 2003 Aug; 59(8):93-104; commentary 103-4. PubMed ID: 14560324
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Pharmacological norepinephrine transporter inhibition for the prevention of vasovagal syncope in young and adult subjects: A systematic review and meta-analysis.
    Lei LY; Raj SR; Sheldon RS
    Heart Rhythm; 2020 Jul; 17(7):1151-1158. PubMed ID: 32151742
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Vasovagal syncope].
    Nellessen E; Melon P; Kulbertus H
    Rev Med Liege; 1997 May; 52(5):324-8. PubMed ID: 9273633
    [No Abstract]   [Full Text] [Related]  

  • 99. [Effectiveness of paroxetine in the treatment of refractory vasovagal syncope in young patients].
    Di Girolamo E; Di Iorio C; Leonzio L; Sabatini P; Ranalli G; Barsotti A
    G Ital Cardiol; 1999 Dec; 29(12):1472-7. PubMed ID: 10687110
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The DDDR closed loop stimulation for the prevention of vasovagal syncope: results from the INVASY prospective feasibility registry.
    Occhetta E; Bortnik M; Vassanelli C;
    Europace; 2003 Apr; 5(2):153-62. PubMed ID: 12633640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.